- Home
- CMRE vs OCUL Comparison
CMRE vs OCUL Comparison
Compare CMRE & OCUL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CMRE | OCUL |
|---|---|---|
| Founded | 1974 | 2006 |
| Country | Monaco | United States |
| Employees | 1880 | N/A |
| Industry | Marine Transportation | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.0B | 1.9B |
| IPO Year | N/A | 2014 |
Fundamental Metrics
Financial Performance| Metric | CMRE | OCUL |
|---|---|---|
| Price | $16.59 | $9.33 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 1 | 9 |
| Target Price | $12.00 | ★ $23.56 |
| AVG Volume (30 Days) | 298.3K | ★ 3.2M |
| Earning Date | 04-29-2026 | 05-05-2026 |
| Dividend Yield | ★ 2.75% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $1,990,000.00 |
| Revenue This Year | N/A | $7.93 |
| Revenue Next Year | N/A | $96.07 |
| P/E Ratio | $5.55 | ★ N/A |
| Revenue Growth | N/A | ★ 3.48 |
| 52 Week Low | $6.63 | $6.23 |
| 52 Week High | $18.06 | $16.44 |
Technical Indicators
Market Signals| Indicator | CMRE | OCUL |
|---|---|---|
| Relative Strength Index (RSI) | 46.88 | 53.40 |
| Support Level | $16.15 | $8.36 |
| Resistance Level | $17.73 | $9.86 |
| Average True Range (ATR) | 0.50 | 0.50 |
| MACD | -0.08 | 0.07 |
| Stochastic Oscillator | 33.57 | 60.62 |
Price Performance
Historical ComparisonAbout CMRE Costamare Inc. $0.0001 par value
Costamare Inc is an international owner and operator of containerships and dry bulk vessels. The company charter its containerships to the liner companies, providing transportation of containerized cargoes. It charter its dry bulk vessels to a wide variety of customers, providing transportation for dry bulk cargoes. The company's fleet of vessels includes Cosco Guangzhou, Cosco Ningbo, Cosco Yantian, Vantage, Valor, Valiant, Maersk Kobe, and others. The company provides services to ocean carriers that demand a high standard of safety and reliability. It generates a majority of its revenue from the United States of America.
About OCUL Ocular Therapeutix Inc.
Ocular Therapeutix Inc is a biotechnology company that specializes in therapies for diseases and conditions of the eye. The company uses its proprietary hydrogel platform technology to deliver therapeutic agents to the eye. Its pipeline consists of eye medication that aims to overcome the limitations of current eye-drop-based therapies for ophthalmic diseases and conditions. Its pipeline product includes Dextenza, OTX-TIC, OTX-TKI, and OTX-IVT.